The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challenges
Scala M, Fabbri C, Fusar-Poli P, Di Lorenzo G, Ferrara M, Amerio A, Fusar-Poli L, Pichiecchio A, Asteggiano C, Menchetti M, De Ronchi D, Sub-Project M, Fanelli G, Serretti A. The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challenges. CNS Spectrums 2024, 29: 570-584. PMID: 39655426, DOI: 10.1017/s1092852924002268.Peer-Reviewed Original ResearchAnxiety disordersPost-traumatic stress disorderPsychedelic-assisted psychotherapyObsessive-compulsive disorderSubstance use disordersPsychotic spectrumStandard antidepressantsResearch to clinical practiceTreating moodStress disorderAddictive behaviorsPsychopharmacological researchPsychiatric conditionsPsilocybinEvidence of efficacyAnxietyMethodological limitationsDisordersMoodMethodological constraintsMethodological rigorEvidence basePotential paradigm shiftLong-term efficacyCultural stigma
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply